ClinVar Miner

Submissions for variant NM_000303.3(PMM2):c.712C>T (p.Arg238Cys)

gnomAD frequency: 0.00003  dbSNP: rs142459706
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000871793 SCV001013506 likely benign PMM2-congenital disorder of glycosylation 2024-01-29 criteria provided, single submitter clinical testing
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital RCV000871793 SCV001984667 likely benign PMM2-congenital disorder of glycosylation 2020-03-26 criteria provided, single submitter clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000871793 SCV002495898 uncertain significance PMM2-congenital disorder of glycosylation 2022-01-27 criteria provided, single submitter clinical testing PMM2 NM_000303.2 exon 8 p.Arg238Cys (c.712C>T): This variant has not been reported in the literature but is present in 0.8% (251/30612) of South Asian alleles including 2 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-8941653-C-T?dataset=gnomad_r2_1). This variant amino acid Cysteine (Cys) is present in multiple species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools are unclear. This variant is present in ClinVar, with multiple labs classifying this variant as Likely Benign (Variation ID:702628). However, other variants at this position have been reported in association with disease (p.Arg238Pro, p.Arg238His) suggesting that this codon may have functional significance. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Natera, Inc. RCV000871793 SCV002092455 benign PMM2-congenital disorder of glycosylation 2020-04-17 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003948174 SCV004762637 benign PMM2-related disorder 2024-01-29 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.